Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Undergraduate School

Carleton College

1978, Northfield, MN

Medical School

Harvard Medical School

1982, Boston, MA

Internship

Boston Children's Hospital

1983, Boston, MA

Residency

Boston Children's Hospital

1985, Boston, MA

Fellowship

Pediatric Gastroenterology and Nutrition

New England Medical Center Hospital, The Floating Hospital for Children

1988, Boston, MA

Fellowship

Research in Division of Molecular Medicine

New England Medical Center Hospital

1998, Boston, MA

Certifications

  • American Board of Pediatrics (Gastroenterology)
  • American Board of Pediatrics (General)

Media

Caregiver Profile

Meet Dr. Venno Verhave

Publications

  1. Pediatric Collagenous Gastritis: Clinical and Histologic Outcomes in a Large Pediatric Cohort. J Pediatr Gastroenterol Nutr. 2021 10 01; 73(4):513-519. View Abstract

  2. Where Did the Blood Go?: A Meckel's Diverticulum Bleed Without Hematochezia or Melena. JPGN Rep. 2021 Nov; 2(4):e119. View Abstract

  3. Pediatric Collagenous Gastroenterocolitis Successfully Treated with Methotrexate. Case Rep Pediatr. 2020; 2020:1929581. View Abstract

  4. Fatal Central Nervous System Disease Following First Infliximab Infusion in a Child With Inflammatory Bowel Disease. Pediatr Neurol. 2016 Apr; 57:91-4. View Abstract

  5. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):343-7. View Abstract

  6. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention. Inflamm Bowel Dis. 2011 Jan; 17(1):458-70. View Abstract

  7. Regulatory regions in the rat lactase-phlorizin hydrolase gene that control cell-specific expression. J Pediatr Gastroenterol Nutr. 2004 Sep; 39(3):275-85. View Abstract

  8. Research agenda for pediatric gastroenterology, hepatology and nutrition: chronic inflammatory bowel disease. Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. J Pediatr Gastroenterol Nutr. 2002; 35 Suppl 3:S286-90. View Abstract

  9. Regulation of rat lactase-phlorizin hydrolase (LPH) by C/EBP and HNF-3. 1999; 116:A567.

  10. Three distinct messenger RNA distribution patterns in human jejunal enterocytes. Gastroenterology. 1998 Jul; 115(1):86-92. View Abstract

  11. Asymmetrical localization of mRNAs in enterocytes of human jejunum. J Histochem Cytochem. 1998 Mar; 46(3):335-43. View Abstract

  12. Distinct mRNA distribution patterns in human jejunal enterocytes. 1998; 26:553.

  13. Demonstration of dual function enhancer and silencer activity in the CE-LPH1 region of the human lactase-phlorizin hydrolase (LPH) gene. 1998; 116:A559.

  14. Clinical Pediatric Gastroenterology. 1998; ; 229-233.

  15. Three distrinct mRNA distribution patterns in human jejunal enterocytes. 1998; 114:A892.

  16. Rat lactase-phlorizin hydrolase/human growth hormone transgene is expressed on small intestinal villi in transgenic mice. Gastroenterology. 1997 Sep; 113(3):844-55. View Abstract

  17. Thoracoscopic esophagomyotomy for achalasia in a child. J Pediatr Gastroenterol Nutr. 1997 Feb; 24(2):215-7. View Abstract

  18. Targeting of lactase-phlorizin hydrolase (LPH) and sucrase-isomaltase (SI) mRNAs to the apical domain of absorptive enterocytes of human jejunum. 1997; 112:A347.

  19. Identification of a negative cis-acting element in the rat lactase-phlorizin hydrolase (LPH) promoter. 1997; 112:A913.

  20. Lactase-phlorizin hydrolase (LPH) is degraded before its insertion into the microvillus membrane in rats prenatally exposed to ethanol. 1997; 112:A361.

  21. Immunosuppressive therapy for children with inflammatory bowel disease: a retrospective study with long-term follow-up. 1997; 112:A1079.

  22. Ceftriaxone choledocholithiasis. Pediatrics. 1996 Jul; 98(1):133-5. View Abstract

  23. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1996 Apr; 22(3):296-302. View Abstract

  24. Verification of the lactase site of rat lactase-phlorizin hydrolase by site-directed mutagenesis. Gastroenterology. 1995 Oct; 109(4):1234-40. View Abstract

  25. Further characterization of the 5'-flanking region of the rat lactase-phlorizin hydrolase gene. Biochem Biophys Res Commun. 1995 Apr 26; 209(3):989-95. View Abstract

  26. Transcriptional regulation of intestinal hydrolase biosynthesis during postnatal development in rats. Am J Physiol. 1994 Oct; 267(4 Pt 1):G584-94. View Abstract

  27. Appropriate cell- and crypt/villus-specific expression of the rat lactase-phlorizin hydrolase gene in transgenic mice. 1994; 106:A244.

  28. Identification of positive and negative transcriptional regulatory regions in the rat lactase-phlorizin hydrolase gene, in Lentze MJ, Naim HY, and Grand RJ (eds). Mammalian Brush Border Membrane Proteins II. 1994; 26-29.

  29. Combined use of cyclosporin A (CSA) and azathioprine (AZA) in pediatric inflammatory bowel disease (IBD). 1994; 106:A23.

  30. Lactase: origin, gene expression, localization, and function. 1994; (14):781-805.

  31. Combined use of cyclosporin A (CSA) and azathioprine (AZA) in pediatric inflammatory bowel disease (IBD). 1994; 106:A23.

  32. Rat lactase-phlorizin hydrolase has a single main catalytic site with both ß-glucosidic and ß-galactosidic activities. 1994; 106:A1043.

  33. Identification and treatment of nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children. Am J Dis Child. 1993 Dec; 147(12):1280-1. View Abstract

  34. Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis. J Pediatr. 1993 Apr; 122(4):647-9. View Abstract

  35. Identification of positive and negative transcriptional regulatory regions in the rat lactase-phlorizin hydrolase gene. 1993; 104:A287.

  36. Transcriptional regulation of lactase-phlorizin hydrolase and sucrase-isomaltase in rat intestine. 1993; 104:A630.

  37. Prevalence and treatment of gastroduodenal injury in children with juvenile rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs. 1992; 102(4):A22.

  38. Expression of the rat intestinal lactase-phlorizin hydrolase gene along the proximal to distal axis and during postnatal development. 1992; (3):199A.

  39. Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem. 1991 Feb 25; 266(6):3882-7. View Abstract

  40. Azathioprine in the treatment of children with inflammatory bowel disease. J Pediatr. 1990 Nov; 117(5):809-14. View Abstract

  41. Somatostatin gene regulation: an overview. Metabolism. 1990 Sep; 39(9 Suppl 2):2-5. View Abstract

  42. Regulation of somatostatin gene expression, in Schwartz T (ed). Neuropeptides and Their Receptors. 1990; 60-70.

  43. Regulation of expression of the human pre-pro VIP gene, in Wass J and Scanlon M (eds). Neuroendocrine Perspectives. 1989; 6.

  44. Regulation of somatostatin gene expression by phorbol esters. Presented at the American Gastroenterological Association 1989. 1989; 96:A527.

  45. Fos and jun cooperate to activate transcription of the human VIP gene. Society for Neuroscience Abstracts. 1989; (15):1124.

  46. The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc Natl Acad Sci U S A. 1988 Sep; 85(18):6662-6. View Abstract

  47. The relevance of DNA mediated gene transfer in mammalian cells for neuroscience, in van Leeuwen FW, Buijs RM, Pool CW, and Pach O, (eds). Techniques in the Behavioual and Neural Sciences: Molecular Neuroanatomy. 1988; 3:79-94.

  48. Presented at the American Gastroenterological Association 1988. 1988; (94):A479.

  49. Characterization of a cyclic AMP responsive enhancer element in the human VIP gene. 1987.

  50. Efficacy and safety of azathioprine in children with IBD. Presented at the American Gastroenterological Association 1987. 1987; 92(5):1682.

  51. Mutational analysis of a cyclic AMP responsive element in the human VIP gene. 1987; 13(1):34.

  52. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system. J Clin Lab Immunol. 1982 Apr; 7(3):193-8. View Abstract
BESbswy